---
title: MOA video on the principle of proprietary technology for BreyeTx
description: High-quality 3D animation detailing Danegaptide's mechanism of action for diabetic retinopathy, enhancing patient understanding and treatment visualization.
image: https://nanobot.group/hubfs/Breye%20case%20study%20-%20main.jpg
---

[![Logotype\_white](https://nanobot.group/hubfs/Logotype_white.svg)](https://nanobot.group/?hsLang=en) 

![hamb](https://nanobot.group/hubfs/Life%20science%20marketing%20website/icons8-hamburger-button-32.png)

[About](https://nanobot.group/about?hsLang=en)

Industries

### Industries

#### [![Biotech Startups](https://nanobot.group/hubfs/micro.png) BioTech & MedTech Startups Attract investment & partnerships](https://nanobot.group/biotech-marketing?hsLang=en)

#### [![Life Science Businesses](https://nanobot.group/hubfs/%E2%80%94Pngtree%E2%80%94vector%20dna%20icon_3787609.png) Life Science Businesses Market your services & products, increase your revenue](https://nanobot.group/life-science-marketing?hsLang=en)

#### [![Pharma](https://nanobot.group/hubfs/thread.png) Pharma Build lasting relationships with HCPs and patients](https://nanobot.group/pharma-marketing?hsLang=en)

#### [![Aesthetic Medicine](https://nanobot.group/hubfs/Aesthetic.png) Aesthetic Medicine Developing content and learning solutions](https://nanobot.group/aesthetic-medicine-companies?hsLang=en)

#### [![Medical Devices](https://nanobot.group/hubfs/Medical-devices.png) Medical Devices Explain complex mechanisms & train professionals](https://nanobot.group/medical-device-companies?hsLang=en)

#### [![Academia, Hospitals and Clinics](https://nanobot.group/hubfs/Academia.png) Academia, Hospitals, and Clinics Communicate scientific progress and demonstrate your impact](https://nanobot.group/academia-and-healthcare-institutions?hsLang=en)

Offers

### Offers

#### [![Fundraising bundles](https://nanobot.group/hubfs/Fundraising%20bundles.png) Fundraising bundles Investor-ready assets for Biotech & Medtech startups](https://nanobot.group/fundraising-bundles?hsLang=en)

#### [![Life science retainer](https://nanobot.group/hubfs/Life%20science%20retainer.png) Life science retainer Turn scientific excellence into predictable revenue](https://nanobot.group/life-science-retainer?hsLang=en)

Services

### Strategy

[![Brand Identity](https://nanobot.group/hubfs/Services/Branding%20(1).svg) Brand Identity](https://nanobot.group/branding?hsLang=en)

[![Positioning and Messaging](https://nanobot.group/hubfs/Positioning%20and%20Messaging.svg) Positioning and Messaging](https://nanobot.group/positioning-and-messaging?hsLang=en)

[![Content Strategy](https://nanobot.group/hubfs/Content%20Strategy%20menu%202.svg) Content Strategy](https://nanobot.group/content-strategy?hsLang=en)

### Content

[![E-Detailing and Visual Aids](https://nanobot.group/hubfs/Services/Edetailing.svg) E-Detailing and Visual Aids](https://nanobot.group/edetailing?hsLang=en)

[![Scientific/Medical Animations](https://nanobot.group/hubfs/Services/Medical%20Content.svg) Scientific/Medical Animations](https://nanobot.group/scientific_and_medical_content?hsLang=en)

[![E-Learning](https://nanobot.group/hubfs/E-Learning%20logo.svg) Educational Content/E-Learning](https://nanobot.group/e-learning-solutions?hsLang=en)

[![Pitch decks](https://nanobot.group/hubfs/Pitch%20decks.svg) Pitch Decks](https://nanobot.group/pitch-decks?hsLang=en)

### ROI

[![Sales & Marketing Operations](https://nanobot.group/hubfs/Services/Sales%20%26%20Marketing%20Operations.svg) Sales & Marketing Operations](https://nanobot.group/sales-and-marketing-operations/?hsLang=en)

[![Lead Generation](https://nanobot.group/hubfs/Services/Lead%20Generation.svg) Lead Generation](https://nanobot.group/lead-generation?hsLang=en)

### Technology

[![Website Design & Development](https://nanobot.group/hubfs/Services/Web%20Design.svg) Website Design & Development](https://nanobot.group/web-design?hsLang=en)

[![Interactive Video](https://nanobot.group/hubfs/Interactive%20video%20menu%203.svg) Interactive Video](https://nanobot.group/interactive-video?hsLang=en)

[![Medical Game](https://nanobot.group/hubfs/Medical%20Game.svg) Medical Game](https://nanobot.group/gut-brain-vagus-protocol?hsLang=en)

Resources

### Resources

#### [![Case studies](https://nanobot.group/hubfs/Case%20studies3.png) Case studies A curated showcase of our featured projects and campaigns](https://nanobot.group/cases?hsLang=en)

#### [![Resources](https://nanobot.group/hubfs/Resources3.png) eBooks, webinars, and tools Essential resources and tools to help your business grow](https://nanobot.group/resources?hsLang=en)

#### [![Blog](https://nanobot.group/hubfs/Blog3.png) Blog Expert insights, industry trends, and actionable advice](https://nanobot.group/blog?hsLang=en)

[Get my Quote](https://nanobot.group/contact?hsLang=en)

[Case study](https://nanobot.group/blog/tag/case-study)

# MOA video on the principle of proprietary technology for BreyeTx

08 Jan 2026 **| by Andrii Koniukh**

![Breye case study - main](https://nanobot.group/hs-fs/hubfs/Breye%20case%20study%20-%20main.jpg?width=700&height=417&name=Breye%20case%20study%20-%20main.jpg)

[BACK TO BLOG](https://nanobot.group/blog?hsLang=en)

<http://www.linkedin.com/shareArticle?mini=true&url=https://nanobot.group/blog/moa-video-on-the-principle-of-proprietary-technology-for-breyetx> <http://www.facebook.com/share.php?u=https://nanobot.group/blog/moa-video-on-the-principle-of-proprietary-technology-for-breyetx> <https://twitter.com/intent/tweet?url=https://nanobot.group/blog/moa-video-on-the-principle-of-proprietary-technology-for-breyetx>

<iframe src="https://slides.com/nanobotmedical/breye-case-study-5a3a4e/embed?byline=hidden" width="576" height="420" title="Breye case study" scrolling="no" frameborder="0" webkitallowfullscreen="" mozallowfullscreen="" allowfullscreen style="position: absolute; top: 0px; left: 0px; width: 100%; height: 100%; border: none;"></iframe>

Danegaptide uniquely treats the underlying pathology in patients with diabetic retinopathy, stabilizes intercellular communication, and strengthens both the retina's inner and outer blood barriers, which decreases vascular leakage and protection of capillary structures and helps remove the subretinal fluid.  
Oral danegaptide therapy for these clinically proven conditions has the potential to be a more effective and less burdensome oral therapy for patients with diabetic retinopathy.

## The Goal

"To develop a 3D animation to communicate the mechanism of action of the drug and the process of treating the pathology."

 

![Challenge](https://nanobot.group/hubfs/Life%20science%20marketing%20website/icon%20(8).svg)

### Challenge

![Our Approach](https://nanobot.group/hubfs/Life%20science%20marketing%20website/icon%20(7).svg)

### Our Approach

![Results](https://nanobot.group/hubfs/Life%20science%20marketing%20website/icon%20(2).svg)

### Results

### Outstanding animation feature: achieving the most precise visual effect through a combination of animation techniques

Demonstrated capillaries with endotheliocytes and pericytes, depicting the separation of endothelial cells and the flow of erythrocytes. Describing erythrocyte dynamics was a detailed and time-consuming process, with manual animation ensuring visual accuracy. Proportional vessel narrowing relative to pericytes was achieved through diverse animation techniques.

![Знімок екрана 2024-01-02 о 19.44.31](https://nanobot.group/hs-fs/hubfs/%D0%97%D0%BD%D1%96%D0%BC%D0%BE%D0%BA%20%D0%B5%D0%BA%D1%80%D0%B0%D0%BD%D0%B0%202024-01-02%20%D0%BE%2019.44.31.png?width=700&height=251&name=%D0%97%D0%BD%D1%96%D0%BC%D0%BE%D0%BA%20%D0%B5%D0%BA%D1%80%D0%B0%D0%BD%D0%B0%202024-01-02%20%D0%BE%2019.44.31.png)

 

### Outstanding animation feature: finding the best individual implementation option.

Such details as cells should look presentable and realistic on the video. Therefore, to achieve the best result, we tried dozens of attempts of different combinations of materials, lighting, and structure. Thanks to this approach and the practice of developing a microscopically stylized material, we managed to show a clear and visually appealing result.

![Знімок екрана 2024-01-03 о 15.13.23](https://nanobot.group/hs-fs/hubfs/%D0%97%D0%BD%D1%96%D0%BC%D0%BE%D0%BA%20%D0%B5%D0%BA%D1%80%D0%B0%D0%BD%D0%B0%202024-01-03%20%D0%BE%2015.13.23.png?width=700&height=355&name=%D0%97%D0%BD%D1%96%D0%BC%D0%BE%D0%BA%20%D0%B5%D0%BA%D1%80%D0%B0%D0%BD%D0%B0%202024-01-03%20%D0%BE%2015.13.23.png)

 

### Results

1\. High-quality MOA video about a small molecule drug that protects from capillary breakdown and vascular leakage by stabilizing cell-cell coupling under high glucose stress and hypoxic conditions. 

2\. Illustrations to be used on the website and social media

![Знімок екрана 2024-01-03 о 15.26.17](https://nanobot.group/hs-fs/hubfs/%D0%97%D0%BD%D1%96%D0%BC%D0%BE%D0%BA%20%D0%B5%D0%BA%D1%80%D0%B0%D0%BD%D0%B0%202024-01-03%20%D0%BE%2015.26.17.png?width=700&height=355&name=%D0%97%D0%BD%D1%96%D0%BC%D0%BE%D0%BA%20%D0%B5%D0%BA%D1%80%D0%B0%D0%BD%D0%B0%202024-01-03%20%D0%BE%2015.26.17.png)

 

### *"We had a good iterative design process with the team from Nanobot. They were responsive to our input on biological processes and found good solutions for the design. I am very pleased with the result."*

![Ulrik Mouritzen](https://nanobot.group/hs-fs/hubfs/Ulrik%20Mouritzen.png?width=170&height=170&name=Ulrik%20Mouritzen.png)

### Ulrik Mouritzen

Founder and CEO at Breye Therapeutics ApS

## Sign up for our newsletter

Subscribe

![close](https://f.hubspotusercontent30.net/hubfs/6603436/2020%20-%20Templates/x-pop-up-form.svg)

### LET'S CHAT

## EVERY JOURNEY BEGINS WITH A SINGLE STEP

[Get a free consultation](https://meetings.hubspot.com/n-stetsiuk)

### Sectors

[BioTech & MedTech Startups](https://nanobot.group/biotech-marketing?hsLang=en)

<https://nanobot.group/life-science-marketing?hsLang=en>[Life Science Businesses](https://nanobot.group/life-science-marketing?hsLang=en)

[Pharma](https://nanobot.group/pharma-marketing?hsLang=en)

[Aesthetic Medicine](https://nanobot.group/aesthetic-medicine-companies?hsLang=en)

[Medical Devices](https://nanobot.group/medical-device-companies?hsLang=en)

[Academia, Hospitals, and Clinics](https://nanobot.group/academia-and-healthcare-institutions?hsLang=en)

[Fundraising bundles](https://nanobot.group/biotech-marketing-bundles?hsLang=en)

[Life science retainer](https://nanobot.group/life-science-retainer?hsLang=en)

### Services

[Brand Identity](https://nanobot.group/branding?hsLang=en)

[Positioning and Messaging](https://nanobot.group/positioning-and-messaging?hsLang=en)

[Content Strategy](https://nanobot.group/content-strategy?hsLang=en)

[E-detailing and Visual Aids](https://nanobot.group/edetailing?hsLang=en)

[Scientific & Medical Animations](https://nanobot.group/scientific_and_medical_content?hsLang=en)

[Educational Content / E-Learning](https://nanobot.group/e-learning-solutions?hsLang=en)

[Pitch Decks](https://nanobot.group/pitch-decks?hsLang=en)

<https://nanobot.group/interactive-video?hsLang=en>[Sales & Marketing Operations](https://nanobot.group/sales-and-marketing-operations?hsLang=en)

<https://nanobot.group/paid-advertising-and-abm?hsLang=en>[Lead Generation](https://nanobot.group/lead-generation?hsLang=en)

[Website Design  & Development](https://nanobot.group/web-design?hsLang=en)

[Interactive Video](https://nanobot.group/interactive-video?hsLang=en)

[Medical Game](https://nanobot.group/gut-brain-vagus-protocol?hsLang=en)

### About

[Our story](https://nanobot.group/about?hsLang=en)

[Our Partners](https://nanobot.group/about?section=s4&hsLang=en)

[The Codes we live](https://nanobot.group/about?section=s7&hsLang=en)

[Case studies](https://nanobot.group/cases?hsLang=en)

[eBooks, webinars, and tools](https://nanobot.group/resources?hsLang=en)

[Blog](https://nanobot.group/blog?hsLang=en)

[Terms and Conditions](https://nanobot.group/terms-and-conditions?hsLang=en)

[Privacy Policy](https://nanobot.group/privacy-policy?hsLang=en)

### Contact Us

10572 Bernabe Dr.  
San Diego, CA 92129  
+1 858 207 87 81  
[info(at)nanobotmedical.com](mailto:info@nanobotmedical.com)

---

Estonia  
Nanobot OÜ Tallinn 10142  
+48 799 35 49 38  
[sales(at)nanobotmedical.com](mailto:sales@nanobotmedical.com)

[![Instagram](https://nanobot.group/hubfs/Life%20science%20marketing%20website/icon%20(5).svg)](https://www.instagram.com/sci.nanobotcomms/)     [![Linkedin](https://nanobot.group/hubfs/Life%20science%20marketing%20website/uiw_linkedin.svg)](https://www.linkedin.com/company/nanobotmodels-medical-animation-studio)      [![Youtube](https://nanobot.group/hubfs/Life%20science%20marketing%20website/icon%20(6).svg)](https://www.youtube.com/@Nanobot_comms)

### Our awards

![Снимок\_экрана\_2023-12-07\_в\_14.38 2](https://nanobot.group/hs-fs/hubfs/Life%20science%20marketing%20website/%D0%A1%D0%BD%D0%B8%D0%BC%D0%BE%D0%BA_%D1%8D%D0%BA%D1%80%D0%B0%D0%BD%D0%B0_2023-12-07_%D0%B2_14.38%202.png?width=113&height=144&name=%D0%A1%D0%BD%D0%B8%D0%BC%D0%BE%D0%BA_%D1%8D%D0%BA%D1%80%D0%B0%D0%BD%D0%B0_2023-12-07_%D0%B2_14.38%202.png) ![Снимок\_экрана\_2023-12-07\_в\_14.38 1](https://nanobot.group/hs-fs/hubfs/Life%20science%20marketing%20website/%D0%A1%D0%BD%D0%B8%D0%BC%D0%BE%D0%BA_%D1%8D%D0%BA%D1%80%D0%B0%D0%BD%D0%B0_2023-12-07_%D0%B2_14.38%201.png?width=112&height=144&name=%D0%A1%D0%BD%D0%B8%D0%BC%D0%BE%D0%BA_%D1%8D%D0%BA%D1%80%D0%B0%D0%BD%D0%B0_2023-12-07_%D0%B2_14.38%201.png) ![Снимок\_экрана\_2023-12-07\_в\_14.38 3](https://nanobot.group/hs-fs/hubfs/Life%20science%20marketing%20website/%D0%A1%D0%BD%D0%B8%D0%BC%D0%BE%D0%BA_%D1%8D%D0%BA%D1%80%D0%B0%D0%BD%D0%B0_2023-12-07_%D0%B2_14.38%203.png?width=149&height=144&name=%D0%A1%D0%BD%D0%B8%D0%BC%D0%BE%D0%BA_%D1%8D%D0%BA%D1%80%D0%B0%D0%BD%D0%B0_2023-12-07_%D0%B2_14.38%203.png)

![Top Clutch Seo Company Medical California](https://nanobot.group/hs-fs/hubfs/Top%20Clutch%20Seo%20Company%20Medical%20California.png?width=145&height=157&name=Top%20Clutch%20Seo%20Company%20Medical%20California.png) ![top\_the\_manifest\_video\_production\_company\_germany\_2023\_award](https://nanobot.group/hs-fs/hubfs/top_the_manifest_video_production_company_germany_2023_award.png?width=108&height=157&name=top_the_manifest_video_production_company_germany_2023_award.png) ![Top Clutch Video Production Company Medical 2025](https://nanobot.group/hs-fs/hubfs/Top%20Clutch%20Video%20Production%20Company%20Medical%202025.png?width=145&height=157&name=Top%20Clutch%20Video%20Production%20Company%20Medical%202025.png) ![Outlined](https://nanobot.group/hs-fs/hubfs/Life%20science%20marketing%20website/Outlined.png?width=145&height=144&name=Outlined.png)

```json
{
  "@context" : "https://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Andrii Koniukh",
    "url" : "https://nanobot.group/blog/author/andrii-koniukh"
  },
  "dateModified" : "2026-01-08T13:56:13.803Z",
  "datePublished" : "2026-01-08T13:53:23.000Z",
  "headline" : "MOA video on the principle of proprietary technology for BreyeTx",
  "image" : [ "https://nanobot.group/hubfs/Breye%20case%20study%20-%20main.jpg" ],
  "mainEntityOfPage" : {
    "@id" : "https://nanobot.group/blog/moa-video-on-the-principle-of-proprietary-technology-for-breyetx",
    "@type" : "WebPage"
  },
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "url" : "https://nanobot.group/hubfs/Logotype_color_black%20(4).svg"
    },
    "name" : "Nanobot OÜ"
  }
}
```